NCT02991599View on ClinicalTrials.gov

Immunogenicity of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

May 31, 2018

Conditions
Hepatitis B Vaccine
Interventions
BIOLOGICAL

60 µg dose hepatitis B vaccine

three-dose, 60 µg per dose

BIOLOGICAL

20 µg dose hepatitis B vaccine

three-dose, 20 µg per dose

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention, China

OTHER_GOV

lead

Shanxi Medical University

OTHER

NCT02991599 - Immunogenicity of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients | Biotech Hunter | Biotech Hunter